[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69723456D1 - 1-(3-aminoindazol-5-yl)-3-phenylmethyl cyclische harnstoffe und ihre verwendung als hiv protease inhibitoren - Google Patents

1-(3-aminoindazol-5-yl)-3-phenylmethyl cyclische harnstoffe und ihre verwendung als hiv protease inhibitoren

Info

Publication number
DE69723456D1
DE69723456D1 DE69723456T DE69723456T DE69723456D1 DE 69723456 D1 DE69723456 D1 DE 69723456D1 DE 69723456 T DE69723456 T DE 69723456T DE 69723456 T DE69723456 T DE 69723456T DE 69723456 D1 DE69723456 D1 DE 69723456D1
Authority
DE
Germany
Prior art keywords
hiv protease
aminoindazol
phenylmethyl
protease inhibitors
cyclic ureas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69723456T
Other languages
English (en)
Other versions
DE69723456T2 (de
Inventor
James David Rodgers
Robert Frank Kaltenbach Iii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Publication of DE69723456D1 publication Critical patent/DE69723456D1/de
Application granted granted Critical
Publication of DE69723456T2 publication Critical patent/DE69723456T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69723456T 1996-11-08 1997-11-04 1-(3-aminoindazol-5-yl)-3-phenylmethyl cyclische harnstoffe und ihre verwendung als hiv protease inhibitoren Expired - Fee Related DE69723456T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US74710496A 1996-11-08 1996-11-08
US2974596P 1996-11-08 1996-11-08
US29745P 1996-11-08
US747104 1996-11-08
PCT/US1997/020035 WO1998020008A1 (en) 1996-11-08 1997-11-04 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors

Publications (2)

Publication Number Publication Date
DE69723456D1 true DE69723456D1 (de) 2003-08-14
DE69723456T2 DE69723456T2 (de) 2004-05-27

Family

ID=26705293

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69723456T Expired - Fee Related DE69723456T2 (de) 1996-11-08 1997-11-04 1-(3-aminoindazol-5-yl)-3-phenylmethyl cyclische harnstoffe und ihre verwendung als hiv protease inhibitoren

Country Status (21)

Country Link
EP (1) EP0937067B1 (de)
JP (1) JP2001503428A (de)
KR (1) KR20000053122A (de)
CN (1) CN1235602A (de)
AT (1) ATE244714T1 (de)
AU (1) AU5165198A (de)
BR (1) BR9712910A (de)
CA (1) CA2270966A1 (de)
CZ (1) CZ157599A3 (de)
DE (1) DE69723456T2 (de)
EA (1) EA199900452A1 (de)
EE (1) EE9900188A (de)
ES (1) ES2202645T3 (de)
HU (1) HUP9904676A2 (de)
IL (1) IL129727A0 (de)
LV (1) LV12375B (de)
NO (1) NO992228L (de)
PL (1) PL333421A1 (de)
SI (1) SI20074A (de)
SK (1) SK59699A3 (de)
WO (1) WO1998020008A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0973767A1 (de) * 1997-03-31 2000-01-26 Dupont Pharmaceuticals Company Indazol zyklische harnstoffderivate als hiv protease-hemmer
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
PL1981851T3 (pl) 2006-01-31 2012-07-31 Array Biopharma Inc Inhibitory kinazy i sposoby ich stosowania

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5532357A (en) * 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas

Also Published As

Publication number Publication date
AU5165198A (en) 1998-05-29
EA199900452A1 (ru) 2000-02-28
EP0937067B1 (de) 2003-07-09
SK59699A3 (en) 1999-12-10
PL333421A1 (en) 1999-12-06
EP0937067A1 (de) 1999-08-25
JP2001503428A (ja) 2001-03-13
SI20074A (sl) 2000-04-30
HUP9904676A2 (hu) 2000-06-28
DE69723456T2 (de) 2004-05-27
ATE244714T1 (de) 2003-07-15
KR20000053122A (ko) 2000-08-25
ES2202645T3 (es) 2004-04-01
WO1998020008A1 (en) 1998-05-14
CZ157599A3 (cs) 1999-11-17
CN1235602A (zh) 1999-11-17
BR9712910A (pt) 2000-03-21
LV12375B (en) 2000-04-20
IL129727A0 (en) 2000-02-29
NO992228L (no) 1999-06-07
CA2270966A1 (en) 1998-05-14
EE9900188A (et) 1999-12-15
NO992228D0 (no) 1999-05-07
LV12375A (lv) 1999-11-20

Similar Documents

Publication Publication Date Title
ATE264846T1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
EA199900907A1 (ru) 4,4-дизамещенные 3,4-дигидро-2(1н)-хиназолиноны, полезные в качестве ингибиторов обратной транскриптазы вич
AP2003002915A0 (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis.
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
BR9806752A (pt) Ftalazinonas.
NO20022095L (no) Heterocyklisk substituerte pyrazoloner
ATE37375T1 (de) Phosphonyl-hydroxyacyl-aminosaeure-derivate und ihre verwendung als antihypertensiva.
TR199901710T2 (xx) IL-8 resept�r antagonistleri.
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
ATE267200T1 (de) Bicyclische kinase inhibitoren
DE60211539D1 (de) Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion
ATE255584T1 (de) Pyrimidinverbindungen und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität
SE9804212D0 (sv) Compounds
TR199901761T2 (xx) IL-8 resept�r antagonistleri.
YU62504A (sh) Triciklična 2-pirimidonska jedinjenja korisna kao inhibitori hiv reverzne transkriptoze
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
TR200003065T2 (tr) Nöraminidazların inhibitörleri olarak pirolidinler.
ATE244714T1 (de) 1-(3-aminoindazol-5-yl)-3-phenylmethyl cyclische harnstoffe und ihre verwendung als hiv protease inhibitoren
EA200600560A1 (ru) Ингибиторы проникновения вируса вич
SE9904128D0 (sv) Novel compounds
EA200000522A1 (ru) 5-htагонисты
LT2003003A (en) Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors
DK1178985T3 (da) Substituerede thienocycloalk(en)ylamino-1,3,5-triaziner
WO2000073284A3 (en) 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
EA199900451A1 (ru) (4r,5s,6s,7r)-гексагидро-1-[5-(3-аминоиндазол)метил]-3-бутил-5,6-дигидрокси-4,7-бис[фенилметил]-2н-1,3-диазепин-2-он, его получение и его применение в качестве ингибитора вич-протеазы

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee